S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity

Experimental Neurology

Volumn 143, Issue 2, 1997, Pages 282-286

  Matthews, Russell T ^a   Yang, Lichuan ^a   Beal, M Flint ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ARGININE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; ENZYME INHIBITOR; HOMOVANILLIC ACID; MALONIC ACID; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; S METHYLTHIOCITRULLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031079599     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.6406     Document Type: Article

References (24)

1. Beal M. F., Brouillet E., Jenkins B., Henshaw R., Rosen B., Hyman B. T. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61:1993;1147-1150.
2. 10. Ann. Neurol. 36:1994;882-888.
3. Beal M. F., Matson W. R., Swartz K. J., Gamache P. H., Bird E. D. Kynurenine pathway measurements in Huntington's disease striatum: Evidence for reduced formation of kynurenic acid. J. Neurochem. 55:1990;1327-1339.
4. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
5. Beckman J. S., Ischiropoulos H., Zhu L., van der Woerd M., Smith C., Chen J., Harrison J., Martin J. C., Tsai M. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch. Biochem. Biophys. 298:1992;438-445.
6. Bederson J. B., Pitts L. H., Germano S. M., Nishimura M. C., Davis R. L., Bartkowski H. M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;1304-1308.
7. Chan P., DeLanney L. E., Irwin I., Langston J. W., DiMonte D. Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J. Neurochem. 57:1991;348-351.
8. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., Snyder S. H. Mechanisms of nitric oxide mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
9. Floyd R. A., Watson J. J., Wong P. K. Sensitive assay of hydroxyl radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J. Biochem. Biophys. Methods. 10:1984;221-235.
10. Furfine E. S., Harmon M. F., Paith J. E., Knowles R. G., Salter M., Kiff R. J., Duffy C., Hazelwood R., Oplinger J. A., Garvey E. P. Potent and selective inhibition of human nitric oxide synthases. J. Biol. Chem. 269:1994;26677-22668.
11. Gluck M. R., Krueger M. J., Ramsey R. R., Sabin S. O., Singer T. P., Nicklas W. J. Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparation. J. Biol. Chem. 269:1994;3167-3174.
12. Greene J. G., Porter H. P., Eller R. V., Greenamyre J. T. Inhibition of succinate dehydrogenase by malonic acid produces an excitotoxic lesion in rat striatum. J. Neurochem. 61:1993;1151-1154.
13. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R. T., Beal M. F. Inhibition of neuronal nitric oxide synthase prevents MPTP induced parkinsonism in baboons. Nat. Med. 2:1996;1-5.
14. Henshaw R., Jenkins B. G., Schulz J. B., Ferrante R. J., Kowall N. W., Rosen B. R., Beal M. F. Malonate produces striatal lesions by indirect NMDA receptor activation. Brain Res. 647:1994;161-166.
15. Hunot S., Boissiere F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., Hirsch E. C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience. 72:1996;355-363.
16. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J. C., Smith C. D., Beckman J. S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298:1992;431-437.
17. Maragos W. F., Silverstein F. S. Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats. J. Neurochem. 64:1995;2362-2365.
18. Przedborski S., Jackon-Lewis V., Yokoyama R., Shibata T., Dawson V. L., Dawson T. M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93:1996;4565-4571.
19. Schulz J. B., Henshaw D. R., Siwek D., Jenkins B. G., Ferrante R. J., Cipolloni P. B., Kowall N. W., Rosen B. R., Beal M. F. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64:1995;2239-2247.
20. Schulz J. B., Matthews R. T., Jenkins B. G., Ferrante R. J., Siwek D., Henshaw D. R., Cipolloni P. B., Mecocci P., Kowall N. W., Rosen B. R., Beal M. F. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15:1995;8419-8429.
21. Schulz J. B., Matthews R. T., Muqit M. M. K., Browne S. E., Beal M. F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
22. Southan G. J., Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51:1996;383-394.
23. Tipton K. F., Singer T. P. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61:1993;1191-1206.
24. Uppu R. M., Squadrito G. L., Pryor W. A. Acceleration of peroxynitrite oxidations by carbon dioxide. Arch. Biochem. Biophys. 327:1996;335-343.